Bioequivalence Study in Healthy Volunteers

Bausch Health

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: MOA-728

Study type: Interventional

Funder types: Industry

Identifiers

NCT00387985

3200K1-103

Details and patient eligibility

About

Primary: To determine the bioequivalence between the new formulation and the current formulation of the investigational drug, MOA-728.

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG).

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)